Director/PDMR Shareholding

RNS Number : 7289N

GlaxoSmithKline PLC

02 October 2012

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 28 September 2012, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.37 per Ordinary Share, and notional ADSs at a price of $46.52 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2012 to 30 September 2012:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,348.643
Professor Sir Roy Anderson	456.681
Dr Stephanie Burns		443.463
Stacey Cartwright	326.200
Sir Crispin Davis	1,652.749
Lynn  Elsenhans		570.166
Judy Lewent		221.731
Sir Deryck Maughan		886.925
Dr Daniel Podolsky		855.249
Tom de Swaan	674.148
Jing Ulrich		158.379
Sir Robert Wilson	456.681

The Company and the Non-Executive Directors were informed of these allocations on 1 October 2012.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

2 October 2012

 

END

 

 

RDSLLLFBLBFEFBV